D DATAVANT

Serial Number 79256575
Registration 6026113
700

Registration Progress

Application Filed
Dec 13, 2018
Under Examination
Approved for Publication
Jan 21, 2020
Published for Opposition
Jan 21, 2020
Registered
Apr 7, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-04-07)
Due: Apr 07, 2026 150 days

Trademark Image

D DATAVANT

Basic Information

Serial Number
79256575
Registration Number
6026113
Filing Date
December 13, 2018
Registration Date
April 7, 2020
Published for Opposition
January 21, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 7, 2020
Registration
Registered
Classes
009 035 042

Rights Holder

Datavant, Inc.

77
Address
2222 W. Dunlap Avenue,
Suite 250 Phoenix AZ 85021
US

Ownership History

Roivant Sciences GmbH

Original Applicant
27
CH

Datavant, Inc.

New Owner Before Publication #1
03
US

Datavant, Inc.

Owner at Publication
03
US

Datavant, Inc.

Original Registrant
03
US

Datavant, Inc.

New Owner After Registration #1
77
US

Legal Representation

Attorney
Sean D. Detweiler

USPTO Deadlines

Next Deadline
150 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-04-07)
Due Date
April 07, 2026
Grace Period Ends
October 07, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
May 15, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Apr 7, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Jun 29, 2024 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Sep 5, 2020 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Aug 14, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Aug 14, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jul 7, 2020 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 7, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 21, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 21, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 17, 2020 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jan 1, 2020 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jan 1, 2020 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 1, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 17, 2019 ALIE A ASSIGNED TO LIE Loading...
Dec 14, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 13, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 13, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 13, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 13, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 3, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 3, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 3, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 3, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 13, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 13, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 13, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 13, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 31, 2019 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 16, 2019 CREV I CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Loading...
Oct 12, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 12, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Oct 12, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 12, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 16, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 16, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 8, 2019 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jul 26, 2019 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Jul 10, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 10, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 28, 2019 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 27, 2019 CHLD M CHANGE OF OWNER RECEIVED FROM IB Loading...
Jun 3, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 3, 2019 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 12, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 11, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 7, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 3, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 3, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
May 2, 2019 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...

Detailed Classifications

Class 009
Downloadable computer software for transmitting, analyzing and generating reports; downloadable Computer software for data processing in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for providing, analyzing and generating reports in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for data processing; Downloadable computer programs and computer operating systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; Downloadable computer programs and computer operating systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; Downloadable artificial intelligence and machine learning software for statistical analysis, consultancy and reporting; Downloadable software for analytics in the field of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and development, clinical trials as well as post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Downloadable software for data linkage, discovery, and de-identification used in the fields of healthcare, biomedical research, and clinical trial data for the provision of medical services, public health services and healthcare services; Downloadable computer software for database integration; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software featuring an electronic computer database for linking, viewing, and de-identifying healthcare and healthcare related data used in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for accessing data and information related to healthcare services, patient medical information and clinical trial data and for controlling and managing data and information related to healthcare services, patient medical information and clinical trial data; none of the foregoing directly related to video surveillance or video based security apparatus
Class 035
Advertising; business management; business administration; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business data analysis and professional business consultancy services regarding statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; business analysis and statistical analysis of healthcare data, biomedical research and clinical trial data; systematization and compilation of data in computer databases; compilation of information into computer databases for research and analysis purposes in the fields of public health, healthcare, biomedicine, biotechnology, pharmaceuticals, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; professional business analysis, business consultancy and statistical analysis for business purposes in the fields of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and developments, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes
Class 042
Scientific and technological services, namely, medical research and scientific research, chemical analysis in the healthcare and biomedical field; Scientific research; Chemical analysis for industrial purposes; Biomedical research services; Design and development of computer software; Cloud computing featuring software for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data; Scientific data processing analysis services; Pharmaceutical and biomedical research services, conducting clinical trials for others, post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding analytics in the fields of public health, healthcare, pharmaceuticals, biomedical research and clinical trial data; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding information in the fields of public health, healthcare, pharmaceuticals, biomedical research and clinical trials; Providing temporary use of non-downloadable software applications accessible via a web site for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding data in the fields of public health, healthcare, pharmaceuticals, biomedical research, patient data, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research and pharmacoepidemiological research; Providing technological online information in the fields of public health, healthcare, pharmaceuticals, patient data, biomedical research, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific online information online in the fields of public health, healthcare, pharmaceuticals, patient data, biomedical research, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific research information in the field of biomedicine, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Scientific analysis in the field of scientific data relating to biomedical research and clinical trials; Research and analysis services in the scientific fields of artificial intelligence and machine learning analytics for biomedical research and healthcare institutions

Additional Information

Design Mark
The mark consists of stylized lowercase blue "D" inside of a blue hexagon which has a break at the top right. Above the stylized lowercase blue "D" are three blue squares. Below the hexagon image is the wording "DATAVANT" in black text. The mark is displayed on a white background which is not claimed as a feature of the mark.
Color Claim
The colors black and blue are claimed as a feature of the mark.

Classification

International Classes
009 035 042